These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6491654)

  • 1. Behavioral and biochemical effects of subchronic treatment with (-)3-(3-hydroxyphenyl)-N-n-propylpiperidine in the rat: dopamine receptor sensitivity and tolerance.
    Ahlenius S; Hillegaart V; Magnusson O; Lundström J
    J Neural Transm; 1984; 60(2):103-13. PubMed ID: 6491654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
    Kelly E; Jenner P; Marsden CD
    Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.
    Koch SW; Koe BK; Bacopoulos NG
    Eur J Pharmacol; 1983 Sep; 92(3-4):279-83. PubMed ID: 6138267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
    Jackson D; Carlsson A; Hjorth S; Lindberg P
    J Neural Transm; 1982; 53(4):233-45. PubMed ID: 6286867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity: evidence for the functional importance of somatodendritic autoreceptors.
    Ahlenius S
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):516-22. PubMed ID: 1356231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D; Hjorth S; Carlsson A
    Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes.
    Hjorth S; Clark D; Svensson K; Carlsson A; Thorberg O
    J Neural Transm; 1985; 64(3-4):187-98. PubMed ID: 3936899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D; Salah RS; Galloway MP
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C; De Lucia R; Bernardi MM; Aizenstein ML
    Eur J Pharmacol; 1985 May; 112(1):11-6. PubMed ID: 4040467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics.
    Rollema H; Mastebroek D; Wikström H; Svensson K; Carlsson A; Sundell S
    J Med Chem; 1986 Oct; 29(10):1889-95. PubMed ID: 3761308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.
    Lundström J; Lindgren JE; Ahlenius S; Hillegaart V
    J Pharmacol Exp Ther; 1992 Jul; 262(1):41-7. PubMed ID: 1352554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism by haloperidol of the suppression of exploratory locomotor activity induced by the local application of (-)3-(3-hydroxyphenyl)-N-n-propylpiperidine into the nucleus accumbens of the rat.
    Ahlenius S; Svensson L; Hillegaart V; Thorberg O
    Experientia; 1984 Aug; 40(8):858-9. PubMed ID: 6468602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dopaminergic drugs on striatal acetylcholine concentration.
    Sethy VH; Wenger D
    J Pharm Pharmacol; 1985 Jan; 37(1):73-4. PubMed ID: 2858537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Psychopharmacology (Berl); 1983; 81(3):199-207. PubMed ID: 6139838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens.
    Svensson L; Ahlenius S
    Eur J Pharmacol; 1983 Apr; 88(4):393-7. PubMed ID: 6861878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apomorphine and (+/-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine, injected into the striatum, on the caudate spindle in the rat.
    Hashimoto S; Okuyama S; Aihara H
    Neuropharmacology; 1987 Jul; 26(7A):663-7. PubMed ID: 2888038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.
    Hjorth S; Carlsson A; Clark D; Svensson K; Wikström H; Sanchez D; Lindberg P; Hacksell U; Arvidsson LE; Johansson A
    Psychopharmacology (Berl); 1983; 81(2):89-99. PubMed ID: 6415751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
    Hjorth S; Svensson K; Carlsson A; Wikström H; Andersson B
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):205-18. PubMed ID: 3762735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.